Daniel Maude resumes & CV records
Resumes
Daniel Maude
Engineering Manager At Manufacturing
Location:
Indianapolis, Indiana Area
Industry:
Industrial Automation
Daniel A Maude, 6014044 Nansemond Dr, Carmel, IN 46032
Daniel Maude Phones & Addresses
14044 Nansemond Dr, Carmel, IN 46032 317-8489617
3295 E 104Th St, Carmel, IN 46033 317-4450372
Indianapolis, IN
Mentions for Daniel A Maude
Publications & IP owners
Us Patents
Process For Applying A Decorative Pattern To Earplugs
US Patent:
2001004, Dec 6, 2001
Filed:
May 31, 2001
Appl. No.:
09/871390
Inventors:
Daniel Maude - Carmel IN, US
John Jurney - Carmel IN, US
John Jurney - Carmel IN, US
International Classification:
B41F017/00
US Classification:
101/035000
Abstract:
The present invention provides a printing process for forming a pattern on an earplug. More specifically, the earplug may be orientated and transferred to a printing device which forms the pattern on the earplug. The printing device may comprise an ink jet printer. The pattern may be formed of any number of colors and may comprise a custom logo, printed text decorative pattern or any other pattern.
Quantitative Immunoassay System And Method For Agglutination Assays
US Patent:
5100805, Mar 31, 1992
Filed:
Jan 26, 1989
Appl. No.:
7/301969
Inventors:
Garth E. Ziege - Sheridan IN
Patricia C. Andrews - Camby IN
Andris Indriksons - Zionsville IN
Lawrence E. Kay - Greenwood IN
Jeffrey E. Wright - Indianapolis IN
Daniel A. Maude - Indianapolis IN
Patricia C. Andrews - Camby IN
Andris Indriksons - Zionsville IN
Lawrence E. Kay - Greenwood IN
Jeffrey E. Wright - Indianapolis IN
Daniel A. Maude - Indianapolis IN
Assignee:
Seradyn, Inc. - Indianapolis IN
International Classification:
G01N 33557
US Classification:
436517
Abstract:
An improved, copolymer-based immunoassay system, method, and apparatus is highly sensitive and effective in accurately measuring extremely low concentrations, such as 10. sup. -6 to 10. sup. -12 grams per milliliter, of biologically active substances, such as monoclonal or polyclonal antibodies and antigens, cancer markers, proteins, bacteria, viruses, therapeutic drugs, drugs of abuse, and food and water contaminants in fluid samples. The system requires no sample preparation, and is reliable, easy to use, sufficiently low in cost to be readily usable in doctors' offices, small labs, and other low-volume facilities, but is also readily adaptable to hospital and high-volume use. The new system, method, and apparatus for agglutination immunoassay systems includes novel and coordinated carrier particle technology, light application and measurement and chemistry, coacting to provide the multiple advantages of simplicity and accuracy in use, and extreme sensitivity in application, in quantifying immunoassays.
NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.